Yesterday's SEC filings (494 8-Ks, 24 shelf offerings, 3 S-3s) centered on event-driven restructuring across pharma and small-cap growth.
Top 3
- ADIAL Pharmaceuticals (CIK 1513525) filed 8-K with 8 items including material cost/debt changes, officer departures, and cyber/legal matters nested across sections—body language suggests operational strain with disclosure density flagging structural changes.
- Vireo Growth Inc. (CIK 1771706) filed 5-item 8-K pairing cost recognition with officer transitions and buried asset/lease items, typical of small-cap restructuring cycles.
- Spark I Acquisition Corp (CIK 1884046) filed 4-item 8-K with cost/debt items and material costs, standard SPAC housekeeping.
Paid subscribers see 7 more flagged filings + sector signals—upgrade for $9/mo
FilingFirehose Daily · 2026-06-11